These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17984115)

  • 1. Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73.
    Tannapfel A; John K; Mise N; Schmidt A; Buhlmann S; Ibrahim SM; Pützer BM
    Carcinogenesis; 2008 Jan; 29(1):211-8. PubMed ID: 17984115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in Txnip-deficient mice.
    Sheth SS; Bodnar JS; Ghazalpour A; Thipphavong CK; Tsutsumi S; Tward AD; Demant P; Kodama T; Aburatani H; Lusis AJ
    Oncogene; 2006 Jun; 25(25):3528-36. PubMed ID: 16607285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
    Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
    Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed expression of dominant-negative p73 enables proliferation of cardiomyocytes in mice.
    Ebelt H; Zhang Y; Köhler K; Xu J; Gajawada P; Boettger T; Hollemann T; Müller-Werdan U; Werdan K; Braun T
    J Mol Cell Cardiol; 2008 Sep; 45(3):411-9. PubMed ID: 18634800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
    Farazi PA; Glickman J; Horner J; Depinho RA
    Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
    Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
    Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF; Thorgeirsson SS
    Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models to study the interaction of risk factors for human liver cancer.
    Sell S
    Cancer Res; 2003 Nov; 63(22):7553-62. PubMed ID: 14633666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice.
    Wu YF; Fu SL; Kao CH; Yang CW; Lin CH; Hsu MT; Tsai TF
    Cancer Res; 2008 Mar; 68(6):2033-42. PubMed ID: 18339886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
    Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNp73 a matter of cancer: mechanisms and clinical implications.
    Buhlmann S; Pützer BM
    Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse models of human gastric and hepatic carcinomas.
    Ullrich SJ; Zeng ZZ; Jay G
    Semin Cancer Biol; 1994 Feb; 5(1):61-8. PubMed ID: 8186389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
    Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
    Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
    Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice.
    Vincent F; Bonnin P; Clemessy M; Contrerès JO; Lamandé N; Gasc JM; Vilar J; Hainaud P; Tobelem G; Corvol P; Dupuy E
    Cancer Res; 2009 Apr; 69(7):2853-60. PubMed ID: 19318581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.